Reversible hypophosphatemic rickets following ifosfamide treatment
- 1 January 1992
- journal article
- case report
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 20 (3) , 254-257
- https://doi.org/10.1002/mpo.2950200316
Abstract
A 7‐year‐old boy developed renal tubular dysfunction and hypophosphatemic rickets following treatment for relapsed embryonal rhabdomyosarcoma. Multi‐agent chemotherapy included ifosfamide; the child received a total of 108 g/m2. The complete Fanconi syndrome which ensued, including excessive loss of calcium, resolved spontaneously and progressively 18 months after the last dose of ifosfamide. The patient had no further symptoms of rickets and radiological signs had almost completely normalized. Further follow‐up was not possible as, despite further treatment, the child died of progressive disease.Keywords
This publication has 12 references indexed in Scilit:
- Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumorThe Journal of Pediatrics, 1990
- NEPHROTOXICITY OF IFOSFAMIDE IN CHILDRENThe Lancet, 1989
- Hypophosphataemic rickets after ifosfamide treatment in children.BMJ, 1989
- Ifosfamide-induced renal tubular defectsCancer, 1989
- Fanconi syndrome after ifosfamideCancer Chemotherapy and Pharmacology, 1989
- IfosamideJNCI Journal of the National Cancer Institute, 1988
- Cancer Chemotherapy-Induced Tubular Nephrotoxicity Evaluated by Immunochemical Determination of Urinary Adenosine Deaminase Binding ProteinAmerican Journal of Clinical Pathology, 1986
- Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicityEuropean Journal of Cancer and Clinical Oncology, 1984
- High-dose ifosfamide and mesna as continuous infusion over five days—a phase I/II trialCancer Treatment Reviews, 1983
- Ifosfamide, mesna and vincristine in paediatric oncologyCancer Treatment Reviews, 1983